| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $4,922 | 4 | 100 |
| Duhay Francis | director | 0 | $0 | 4 | $4,922 | $-4,922 |
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical …
Over the last 12 months, insiders at enVVeno Medical Corporation have bought $0 and sold $4,922 worth of enVVeno Medical Corporation stock.
On average, over the past 5 years, insiders at enVVeno Medical Corporation have bought $195,915 and sold $20,275 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 81,433 shares for transaction amount of $249,999 was made by Duhay Francis (director) on 2024‑12‑31.
| 2026-09-11 | Sale | Duhay Francis | director | 11 0.0018% | $11.21 | $123 | -23.36% | |
| 2026-06-11 | Sale | Duhay Francis | director | 140 0.8545% | $10.30 | $1,443 | +1.37% | |
| 2026-03-12 | Sale | Duhay Francis | director | 140 0.8878% | $11.52 | $1,613 | -4.36% | |
| 2025-12-11 | Sale | Duhay Francis | director | 4,900 0.024% | $0.36 | $1,742 | -14.60% | |
| 2025-09-15 | Sale | Duhay Francis | director | 4,900 0.0233% | $0.83 | $4,067 | -65.44% | |
| 2024-12-31 | Duhay Francis | director | 81,433 0.4682% | $3.07 | $249,999 | -2.66% | ||
| 2024-12-31 | Gray Robert | director | 3,500 0.0193% | $2.94 | $10,290 | -2.66% | ||
| 2024-12-24 | Shrivastava Sanjay | director | 5,400 0.0317% | $2.90 | $15,660 | +5.85% | ||
| 2024-12-19 | BERMAN ROBERT ANDREW | Chief Executive Officer | 12,000 0.0687% | $2.55 | $30,600 | +17.98% | ||
| 2024-12-19 | Jenusaitis Matthew | director | 9,620 0.0546% | $2.53 | $24,339 | +17.98% | ||
| 2024-03-13 | Sale | Alavi Hamed | Chief Technology Officer | 8,334 0.0626% | $6.22 | $51,837 | -24.64% | |
| 2022-08-16 | Duhay Francis | 7,751 0.0731% | $6.14 | $47,591 | -11.38% | |||
| 2022-06-30 | Shrivastava Sanjay | 1,000 0.0091% | $3.85 | $3,850 | +39.43% | |||
| 2022-06-27 | BERMAN ROBERT ANDREW | Chief Executive Officer | 2,500 0.0221% | $3.80 | $9,500 | +37.24% | ||
| 2020-08-21 | Sale | Biodyne Holding, S.A. | 75,000 0.1713% | $0.38 | $28,500 | -35.13% | ||
| 2020-08-20 | Sale | Biodyne Holding, S.A. | 75,000 0.1995% | $0.27 | $20,250 | +6.26% | ||
| 2020-08-19 | Sale | Biodyne Holding, S.A. | 50,000 0.138% | $0.30 | $15,000 | -1.33% | ||
| 2020-08-18 | Sale | Biodyne Holding, S.A. | 50,000 0.1493% | $0.34 | $17,000 | -5.20% | ||
| 2020-08-14 | Sale | Biodyne Holding, S.A. | 50,000 0.1353% | $0.31 | $15,500 | -5.04% | ||
| 2020-08-03 | Sale | Biodyne Holding, S.A. | 70,000 0.1916% | $0.32 | $22,400 | -4.44% |
| Increased Positions | 15 | +37.5% | 39,941 | +21.98% |
| Decreased Positions | 15 | -37.5% | 33,786 | -18.6% |
| New Positions | 3 | New | 7,071 | New |
| Sold Out Positions | 3 | Sold Out | 1,596 | Sold Out |
| Total Postitions | 40 | 0% | 187,841 | +3.39% |
| Perceptive Advisors Llc | $616.00 | 8.8% | 1.76M | +474,069 | +36.89% | 2025-09-30 |
| Kingdon Capital Management, L.L.C. | $476.00 | 6.8% | 1.36M | +500,000 | +58.19% | 2025-09-30 |
| Vanguard Group Inc | $301.00 | 4.31% | 861,191 | +162,852 | +23.32% | 2025-09-30 |
| Cm Management, Llc | $210.00 | 3% | 600,000 | +600,000 | New | 2025-09-30 |
| Westside Investment Management, Inc. | $74.00 | 1.06% | 212,800 | -66,725 | -23.87% | 2025-09-30 |
| Geode Capital Management, Llc | $70.00 | 1.01% | 201,244 | +1,735 | +0.87% | 2025-09-30 |
| Jpmorgan Chase & Co | $64.00 | 0.91% | 182,322 | +22 | +0.01% | 2025-09-30 |
| Susquehanna International Group, Llp | $54.00 | 0.77% | 154,471 | +154,471 | New | 2025-09-30 |
| Jane Street Group, Llc | $25.00 | 0.36% | 71,771 | +58,938 | +459.27% | 2025-09-30 |
| Blackrock, Inc. | $21.00 | 0.3% | 59,857 | +2,453 | +4.27% | 2025-09-30 |